CMP : 425
Target Price :
For 2QFY2016, Cadila Healthcare (Cadila) posted better than expected on the
OPM front. Sales came in at Rs2,374cr (V/s our estimate of Rs2,500cr), a yoy
growth of 15.0%. In terms of geographies, US, India and Emerging Markets grew
by 25.2%, 10.3% and 34.9% yoy, respectively. On the operating front, the GPM
came in at 66.0% V/s 60.2% in 2Q..